Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Spurred On By HHS Policy Shift, AdvaMed Chief Wants LDT Reform In User-Fee Negotiations

Sep 14 2020

AdvaMed’s Scott Whitaker — ADVAMED CEO SCOTT WHITAKER IN HIS WASHINGTON, DC, OFFICE IN JANUARY • Source: Ferdous Al-Faruque

Related Content

FDA Passes The Buck On LDTs, But Floats Ideas

Jan 13 2017

COVID-19: CDRH Staff Leaves Door Open For Some LDT Safety Oversight

Sep 08 2020

FDA Makes 2nd Attempt At Virtual MDUFA Public Meeting

Sep 04 2020

Override: HHS Revokes FDA’s LDT Policies

Aug 20 2020

FAQ Sheet From HHS Says FDA ‘Rarely Enforced’ Premarket Review Of LDTs

Aug 29 2020

Unfinished Business: LDT Legislation A Top Priority For Departing FDA Chief Gottlieb

Mar 22 2019

FDA Yanks Potentially Faulty COVID-19 Antibody Tests – And More May Be On The Chopping Block

May 22 2020

AdvaMed CEO Says Some Top Agenda Items For the Year Are ‘Taking A Back Seat’ To Address COVID-19

Apr 17 2020

Additional Topics

United States Regulation Policy Coronavirus COVID-19 Enforcement FDA Legal Issues Legislation Lobbying Safety User Fees In Vitro Diagnostics Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window